DE LUCA, ANDREA
DE LUCA, ANDREA
Dipartimento di Biotecnologie Mediche
"Buffalo hump" in HIV-1 infection RID G-8810-2011
1998-01-01 DE LUCA, Andrea; Murri, R; Damiano, F; Ammassari, A; Antinori, A.
"EFFICACY AND SAFETY OF 2-DRUG COMBINATION ANTIRETROVIRAL THERAPY IN CLINICAL PRACTICE: RESULTS FROM A SINGLE CENTER STUDY"
2018-01-01 Rossetti, B.; Marri, Giacomo; Gonnelli, A.; Toscano, L.; Marri, D.; Galluzzi, P.; Pippi, F.; Carnicelli, N.; Malcontenti, C.; Puttini, C.; Gagliardini, R.; Montagnani, F.; Zanelli, G.; Zazzi, M.; De Luca, A.
233. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF.
1997-01-01 Antinori, A; Ammassari, A; DE LUCA, Andrea; Cingolani, A; Murri, R; Scoppettuolo, G; Fortini, M; Tartaglione, T; Larocca, Lm; Zannoni, G; Cattani, P; Grillo, R; Roselli, R; Iacoangeli, M; Scerrati, M; Ortona, L.
A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads
2006-01-01 COZZI-LEPRI, A; DE LUCA, A; Phillips, An; Bongiovanni, M; DI GIAMBENEDETTO, S; Mena, M; Moioli, Mc; Arlotti, M; Sighinolfi, L; Narciso, P; Lichtner, M; Cauda, R; D'ARMINIO MONFORTE, A
A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients
2002-01-01 VAN LAETHEM, K; DE LUCA, Andrea; Antinori, A; Cingolani, A; Perna, Cf; Vandamme, A. M.
A novel methodology for large-scale phylogeny partition
2011-01-01 Prosperi, Mc; Ciccozzi, M; Fanti, I; Saladini, F; Pecorari, M; Borghi, V; DI GIAMBENEDETTO, S; Bruzzone, B; Capetti, A; Vivarelli, A; Rusconi, S; Re, Mc; Gismondo, Mr; Sighinolfi, L; Gray, Rr; Salemi, M; Zazzi, M.; DE LUCA, A
A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy Regimen
2011-01-01 Prosperi, M. C.; DI GIAMBENEDETTO, S.; Fanti, I.; Meini, G.; Bruzzone, B.; Callegaro, A.; Penco, G.; Bagnarelli, P.; Micheli, V.; Paolini, E.; DI BIAGIO, A.; Ghisetti, V.; DI PIETRO, M.; Zazzi, M.; DE LUCA, A.
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study
2005-01-01 Torti, C; QUIROS-ROLDAN, E; Regazzi, M; DE LUCA, A; Mazzotta, F; Antinori, A; Ladisa, N; Micheli, V; Orani, A; Patroni, A; Villani, P; LO CAPUTO, S; Moretti, F; DI GIAMBENEDETTO, S; Castelnuovo, F; Maggi, P; Tinelli, C; Carosi, G
A whole-genome association study of major determinants for host control of HIV-1 RID A-6681-2009 RID A-2073-2010 RID B-5656-2009 RID F-2587-2010 RID G-8810-2011
2007-01-01 Fellay, J; Shianna, Kv; Ge, Dl; Colombo, S; Ledergerber, B; Weale, M; Zhang, Kl; Gumbs, C; Castagna, A; Cossarizza, A; Cozzi Lepri, A; DE LUCA, Andrea; Easterbrook, P; Francioli, P; Mallal, S; Martinez Picado, J; Miro, Jm; Obel, N; Smith, Jp; Wyniger, J; Descombes, P; Antonarakis, Se; Letvin, Nl; Mcmichael, Aj; Haynes, Bf; Telenti, A; Goldstein, Db
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort
2017-01-01 d'Arminio Monforte, Antonella; Cozzi Lepri, Alessandro; Ceccherini Silberstein, Francesca; DE LUCA, Andrea; Lo Caputo, Sergio; Castagna, Antonella; Mussini, Cristina; Cingolani, Antonella; Tavelli, Alessandro; Shanyinde, Milensu; Gori, Andrea; Girardi, Enrico; Andreoni, Massimo; Antinori, Andrea; Puoti, Massimo
Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: Implications for the activity of next-line regimens from a longitudinal study in Mozambique
2017-01-01 De Luca, Andrea; Sidumo, Zita Jorge; Zanelli, Giacomo; Magid, Noorjehan Abdul; Luhanga, Richard; Brambilla, Davide; Liotta, Giuseppe; Mancinelli, Sandro; Marazzi, Maria Cristina; Palombi, Leonardo; Ceffa, Susanna
Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
1995-01-01 Antinori, A; Murri, R; Ammassari, A; DE LUCA, Andrea; Linzalone, A; Cingolani, A; Damiano, F; Maiuro, G; Vecchiet, J; Scoppettuolo, G.
AIDS-associated cerebral toxoplasmosis: an update on diagnosis and treatment.
1996-01-01 Ammassari, A; Murri, R; Cingolani, A; DE LUCA, Andrea; Antinori, A.
AIDS-related focal brain lesions in the era of highly active antiretroviral therapy RID G-8810-2011 RID A-1577-2008
2000-01-01 Ammassari, A; Cingolani, A; Pezzotti, P; DE LUCA, Andrea; Murri, R; Giancola, Ml; Larocca, Lm; Antinori, A.
Alveolar macrophages from AIDS patients spontaneously produce elevated levels of TNF-alpha in vitro.
1992-01-01 Antinori, A; Tamburrini, E; Pagliari, G; Maiuro, G; Pallavicini, F; DE LUCA, Andrea; Ortona, L.
An outbreak of HIV-1 subtype G among Italian injecting drug users
2007-01-01 Cicozzi, M; Montieri, S; Salemi, M; De Oliveira, T; Dorucci, M; Sinicco, A; DE LUCA, Andrea; Giuliani, M; Balotta, C; Rezza, G.
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project
2015-01-01 Andreoni, M; Marcotullio, S; Puro, V; De Carli, G; Tambussi, G; Nozza, S; Gori, A; Rusconi, S; Santoro, Mm; Clementi, M; Perno, Cf; D'Arminio Monforte, A; Maggiolo, F; Castagna, A; DE LUCA, Andrea; Galli, M; Giacomelli, A; Borderi, M; Guaraldi, G; Calcagno, A; Di Perri, G; Bonora, S; Mussini, C; Di Biagio, A; Puoti, M; Bruno, R; Zuccaro, V; Antinori, A; Cinque, P; Croce, D; Restelli, U; Rizzardini, G; Lazzarin, A.
Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati
2017-01-01 Modica, S.; Didonna, R.; Redi, D.; Spertilli Raffaelli, C.; Cusi, Mg.; De Luca, A.; Montagnani, F.
Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection
2020-01-01 Vergori, Alessandra; Rossetti, Barbara; Vicenti, Ilaria; Meini, Genny; Lentini, Gianluca; Valoriani, Beatrice; Caudai, Cinzia; Morandi, Matteo; Cusi, Maria Grazia; Zazzi, Maurizio; De Luca, Andrea
Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility
2015-01-01 Fabbiani, Massimiliano; Grima, Pierfrancesco; Milanini, Benedetta; Mondi, Annalisa; Baldonero, Eleonora; Ciccarelli, Nicoletta; Cauda, Roberto; Silveri Maria, Caterina; DE LUCA, Andrea; Di Giambenedetto, Simona
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| "Buffalo hump" in HIV-1 infection RID G-8810-2011 | 1-gen-1998 | DE LUCA, Andrea; Murri, R; Damiano, F; Ammassari, A; Antinori, A. | - | |
| "EFFICACY AND SAFETY OF 2-DRUG COMBINATION ANTIRETROVIRAL THERAPY IN CLINICAL PRACTICE: RESULTS FROM A SINGLE CENTER STUDY" | 1-gen-2018 | Rossetti, B.; Marri, Giacomo; Gonnelli, A.; Toscano, L.; Marri, D.; Galluzzi, P.; Pippi, F.; Carnicelli, N.; Malcontenti, C.; Puttini, C.; Gagliardini, R.; Montagnani, F.; Zanelli, G.; Zazzi, M.; De Luca, A. | - | |
| 233. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. | 1-gen-1997 | Antinori, A; Ammassari, A; DE LUCA, Andrea; Cingolani, A; Murri, R; Scoppettuolo, G; Fortini, M; Tartaglione, T; Larocca, Lm; Zannoni, G; Cattani, P; Grillo, R; Roselli, R; Iacoangeli, M; Scerrati, M; Ortona, L. | - | |
| A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads | 1-gen-2006 | COZZI-LEPRI, A; DE LUCA, A; Phillips, An; Bongiovanni, M; DI GIAMBENEDETTO, S; Mena, M; Moioli, Mc; Arlotti, M; Sighinolfi, L; Narciso, P; Lichtner, M; Cauda, R; D'ARMINIO MONFORTE, A | - | |
| A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients | 1-gen-2002 | VAN LAETHEM, K; DE LUCA, Andrea; Antinori, A; Cingolani, A; Perna, Cf; Vandamme, A. M. | - | |
| A novel methodology for large-scale phylogeny partition | 1-gen-2011 | Prosperi, Mc; Ciccozzi, M; Fanti, I; Saladini, F; Pecorari, M; Borghi, V; DI GIAMBENEDETTO, S; Bruzzone, B; Capetti, A; Vivarelli, A; Rusconi, S; Re, Mc; Gismondo, Mr; Sighinolfi, L; Gray, Rr; Salemi, M; Zazzi, M.; DE LUCA, A | - | |
| A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy Regimen | 1-gen-2011 | Prosperi, M. C.; DI GIAMBENEDETTO, S.; Fanti, I.; Meini, G.; Bruzzone, B.; Callegaro, A.; Penco, G.; Bagnarelli, P.; Micheli, V.; Paolini, E.; DI BIAGIO, A.; Ghisetti, V.; DI PIETRO, M.; Zazzi, M.; DE LUCA, A. | - | |
| A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study | 1-gen-2005 | Torti, C; QUIROS-ROLDAN, E; Regazzi, M; DE LUCA, A; Mazzotta, F; Antinori, A; Ladisa, N; Micheli, V; Orani, A; Patroni, A; Villani, P; LO CAPUTO, S; Moretti, F; DI GIAMBENEDETTO, S; Castelnuovo, F; Maggi, P; Tinelli, C; Carosi, G | - | |
| A whole-genome association study of major determinants for host control of HIV-1 RID A-6681-2009 RID A-2073-2010 RID B-5656-2009 RID F-2587-2010 RID G-8810-2011 | 1-gen-2007 | Fellay, J; Shianna, Kv; Ge, Dl; Colombo, S; Ledergerber, B; Weale, M; Zhang, Kl; Gumbs, C; Castagna, A; Cossarizza, A; Cozzi Lepri, A; DE LUCA, Andrea; Easterbrook, P; Francioli, P; Mallal, S; Martinez Picado, J; Miro, Jm; Obel, N; Smith, Jp; Wyniger, J; Descombes, P; Antonarakis, Se; Letvin, Nl; Mcmichael, Aj; Haynes, Bf; Telenti, A; Goldstein, Db | - | |
| Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort | 1-gen-2017 | d'Arminio Monforte, Antonella; Cozzi Lepri, Alessandro; Ceccherini Silberstein, Francesca; DE LUCA, Andrea; Lo Caputo, Sergio; Castagna, Antonella; Mussini, Cristina; Cingolani, Antonella; Tavelli, Alessandro; Shanyinde, Milensu; Gori, Andrea; Girardi, Enrico; Andreoni, Massimo; Antinori, Andrea; Puoti, Massimo | - | |
| Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: Implications for the activity of next-line regimens from a longitudinal study in Mozambique | 1-gen-2017 | De Luca, Andrea; Sidumo, Zita Jorge; Zanelli, Giacomo; Magid, Noorjehan Abdul; Luhanga, Richard; Brambilla, Davide; Liotta, Giuseppe; Mancinelli, Sandro; Marazzi, Maria Cristina; Palombi, Leonardo; Ceffa, Susanna | - | |
| Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. | 1-gen-1995 | Antinori, A; Murri, R; Ammassari, A; DE LUCA, Andrea; Linzalone, A; Cingolani, A; Damiano, F; Maiuro, G; Vecchiet, J; Scoppettuolo, G. | - | |
| AIDS-associated cerebral toxoplasmosis: an update on diagnosis and treatment. | 1-gen-1996 | Ammassari, A; Murri, R; Cingolani, A; DE LUCA, Andrea; Antinori, A. | - | |
| AIDS-related focal brain lesions in the era of highly active antiretroviral therapy RID G-8810-2011 RID A-1577-2008 | 1-gen-2000 | Ammassari, A; Cingolani, A; Pezzotti, P; DE LUCA, Andrea; Murri, R; Giancola, Ml; Larocca, Lm; Antinori, A. | - | |
| Alveolar macrophages from AIDS patients spontaneously produce elevated levels of TNF-alpha in vitro. | 1-gen-1992 | Antinori, A; Tamburrini, E; Pagliari, G; Maiuro, G; Pallavicini, F; DE LUCA, Andrea; Ortona, L. | - | |
| An outbreak of HIV-1 subtype G among Italian injecting drug users | 1-gen-2007 | Cicozzi, M; Montieri, S; Salemi, M; De Oliveira, T; Dorucci, M; Sinicco, A; DE LUCA, Andrea; Giuliani, M; Balotta, C; Rezza, G. | - | |
| An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project | 1-gen-2015 | Andreoni, M; Marcotullio, S; Puro, V; De Carli, G; Tambussi, G; Nozza, S; Gori, A; Rusconi, S; Santoro, Mm; Clementi, M; Perno, Cf; D'Arminio Monforte, A; Maggiolo, F; Castagna, A; DE LUCA, Andrea; Galli, M; Giacomelli, A; Borderi, M; Guaraldi, G; Calcagno, A; Di Perri, G; Bonora, S; Mussini, C; Di Biagio, A; Puoti, M; Bruno, R; Zuccaro, V; Antinori, A; Cinque, P; Croce, D; Restelli, U; Rizzardini, G; Lazzarin, A. | - | |
| Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati | 1-gen-2017 | Modica, S.; Didonna, R.; Redi, D.; Spertilli Raffaelli, C.; Cusi, Mg.; De Luca, A.; Montagnani, F. | - | |
| Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection | 1-gen-2020 | Vergori, Alessandra; Rossetti, Barbara; Vicenti, Ilaria; Meini, Genny; Lentini, Gianluca; Valoriani, Beatrice; Caudai, Cinzia; Morandi, Matteo; Cusi, Maria Grazia; Zazzi, Maurizio; De Luca, Andrea | - | |
| Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility | 1-gen-2015 | Fabbiani, Massimiliano; Grima, Pierfrancesco; Milanini, Benedetta; Mondi, Annalisa; Baldonero, Eleonora; Ciccarelli, Nicoletta; Cauda, Roberto; Silveri Maria, Caterina; DE LUCA, Andrea; Di Giambenedetto, Simona | - |